EFFECTS OF MODIFIED MYCOTOXINS IN POULTRY

Introduction

       The limited data on emerging and modified mycotoxins restricts our understanding of their toxicity. The toxicity of modified mycotoxins can be equal, lower or higher than the mother mycotoxin, but there is little information on this matter. In this case, it is important to consider that poultry exposure to these metabolites may result from the direct ingestion of these modified forms or may be product of the animal´s metabolism.

Modified mycotoxins of zearalenone (ZEN)

       In the case of ZEN, it has been observed that the main metabolite in broiler chickens and laying hens is usually β-zearalenol (β-ZEL), while in turkeys is α-zearalenol (α-ZEL). In all cases, glucuronidation was the major conjugation reaction.

       In poultry, exposure to ZEN is estimated to account for around the 93-100% of cases related to this mycotoxin as there are no data on the modified forms (α-zearalanol (α-ZAL) + β-zearalanol (β-ZAL) + zearalanone (ZAN) + α-ZEL + β-ZEL). However, considering the very high no-observed-adverse-effect levels (NOAEL) for poultry, and the composition of their diets, EFSA (2017) considered the risk of health effects from ZEN and its modified forms to be extremely low for poultry species. Based on the observed reduction in lymphocytes and swelling of the ventricles, turkeys are more resistant to ZEN than chickens (NOAEL: 9100 µg/kg BW vs. 7500 µg/kg BW, respectively).

       The oestrogenic activity (related with toxicity) of ZEN and its metabolites is presented, observing difference between the modified mycotoxins and the mother mycotoxin: α-ZEL > α-ZAL > ZEN = ZAN = β-ZAL > β-ZEL.

Modified mycotoxins of Deoxinivalenol (DON)

       In the case of DON, DON-3-glucoside (DON-3G) is the main plant metabolite of DON and, unlike pigs, chickens do not have the ability to hydrolyse DON-3G back to DON. However, almost complete hydrolysis of 3-acetyl-DON (3-Ac-DON) to DON and partial hydrolysis of 15-acetyl-DON (15-Ac-DON) to DON has been observed (EFSA, 2023). Depending on the mechanism of action on the ribosome, DON-3G, 3-Ac-DON and 15-Ac-DON can be expected to show similar toxicity in the gut. Based on no-observed-adverse-effect levels, turkeys are less sensitive to DON than broilers, hens and ducks.

       Nevertheless, Alizadeh et al. (2016) evaluated the cytotoxicity and impact on intestinal permeability of DON and its modified forms in Caco-2 cells. The results showed that the toxicity of 3-Ac-DON is comparable to DON, although it is less cytotoxic and has a lower impact on permeability. As for 15-Ac-DON, it appears to be slightly more potent than DON while DON-3G and de-epoxy-DON (DOM-1) did not exert measurable adverse effects on the intestinal barrier.

       On the other hand, DON-3-sulfate (DON-3S) is an important metabolite in poultry. Jurisic et al. (2019) evaluated the transfer of this metabolite to eggs and considered that there is no significant risk to public health due to the transfer of DON or DON-3S to eggs, even if the non-toxic DON-3S metabolite per se could be hydrolyzed back to free DON in the intestine of the egg consumer.

Table 1. Summary of in vitro and in vivo studies on the effect of modified mycotoxins in poultry1.

 

ReferenceStudyMycotoxinsEffects
Leitgeb et al. (1999, 2003) reference from EFSA (2014)In vivoBroiler chickens
37 d
800 ppb beauvericin
5600 ppb DON
700 ppb 15-acetylDON
600 ppb ZEN
500 ppb moniliformin
300 ppb NVI
(maize naturally contaminated)
No negative effect on BWG, FCR, liver weight
No differences in meat quality, blood parameters
Leitgeb et al. (1999, 2003) reference from EFSA (2014)In vivoTurkey
11 weeks (growing period)
2480 ppb beauvericin
1200 ppb DON
300 ppb 15-acetylDON
200 ppb ZEN
3000 ppb moniliformin
200 ppb NVI
(maize naturally contaminated)

No differences in BW, FCR

No differences in relative weight of the cooked carcass, spleen, heart, bursa of Fabricius, liver

No differences in blood parameters

CODA-CERVA (2011/2012) reference from EFSA (2014)In vivoBroiler chickens12720 ppb enniatin B
4060 ppb enniatin B1
10310 pb beauvericin
DON
3-acetyl-, 15-acetyl-, de-epoxy-DON
ZEN, α-, β-zearalenol
T2
HT2
No negative effects
Pierron et al. (2016)In vitro

Caco-2

cells

DON
DON-13-glucoside

Cytotoxic,

↑ Intestinal permeability
No effect

Santos and van Eerden (2021)In vivoBroiler chickens
35 d

0-14 d:

2060 vs 878 ppb DON
132 vs 99 ppb DON-3-Glucoside
28 vs 90 ppb enniatin B
13 vs 16 ppb enniatin B1
10 vs 0 ppb alternariol
14-28 d:
2360 vs 941 ppb DON
1670 vs 851 ppb DON-3-Glucoside
0 vs 18 ppb ZEN
40 vs 60 ppb enniatin B
9,5 vs 16 ppb enniatin B1
4,2 vs 3,5 ppb alternariol
28-35 d:
57,3 vs 57,3 ppb DON
8,4 vs 8,4 ppb enniatin B
13 vs 16 ppb enniatin B1
6,1 vs 6,1 beauvericin

↓BWG, ↑FCR (not 28-35d, with a diet marginally contaminated)
↑ VH:CD ileum 14
↓ VH:CD jejunum 28d, ileum 28d
↓VH: jejunum, 28 d, ↑ CD ileum 28d
↑ globe cells ileum 14d
Marker of intestinal lesion: lack in jejunum (not in ileum)
Intestinal viscosity: increased in duodenum 14d
Yunus et al. (2012) reference from EFSA (2023)In vivoBroiler chickens
35 d
1680, 12200 ppb DON
10, 200, 1450 ppb 3-10, 150, 1090 ppb acetyl-DON
ZEN
↓BW, FI
↓ weight/size intestine
↓ VH, CD
Devreese et al. (2014) reference from EFSA (2017)In vivoTurkeys5700 ppb DON, 15-acetylDON↓ VH, villus surface area
Alizadeh et al. (2016)In vitro

Caco-2

cells

DON
DON-3-acetyl
DON-15-acetyl
DON-3-glucoside

Cytotoxic,

↑ intestinal permeability
cytotoxic,

↑ intestinal permeability
↑ cytotoxic,

↑↑ intestinal permeability
No effects

1BW: body weight; BWG: body weight gain; C: crypt depth; FI: feed intake; FCR: food conversion ratio; VH: villus height.

Conclusion

Thus, it is clear that more research is needed on modified mycotoxins derived from the different mycotoxins such as ZEN or DON mentioned, as well as in other cases derived from fumonisins, T2 toxin, etc. given their impact on poultry health.